71
Participants
Start Date
May 18, 2023
Primary Completion Date
January 30, 2026
Study Completion Date
March 31, 2027
Cetrelimab
Cetrelimab will be administered as IV infusion.
Amivantamab
Amivantamab will be administered as IV infusion.
Hosp. Univ. Quiron Dexeus, Barcelona
Aou San Luigi Gonzaga, Orbassano
European Institute of Oncology, Milan
ASST Grande Ospedale Metropolitano Niguarda, Milan
Virginia Cancer Specialists, Fairfax
Hosp. Univ. 12 de Octubre, Madrid
Bakirkoy Sadi Konuk Training and Research Hospital, Istanbul
Goztepe Prof Dr Suleyman Yalcin Sehir Hastanesi, Istanbul
Medicana International Izmir, Izmir
Centro Ricerche Cliniche di Verona S r l, Verona
Hosp. Virgen Macarena, Seville
Instituto Valenciano de Oncologia, Valencia
Sakarya University Training and Research Hospital, Sakarya
University Malaya Medical Centre, Kuala Lumpur
MD Anderson Cancer Center, Houston
Cancer and Blood Specialty Clinic, Los Alamitos
City of Hope, Duarte
City of Hope Orange County Lennar Foundation Cancer Center, Irvine
Hospital Umum Sarawak, Kuching
Providence Portland Medical Center, Portland
Providence Oncology and Hematology Care Clinic Westside, Portland
Fundacao Pio XII, Barretos
Cetus Oncologia, Belo Horizonte
PERSONAL Oncologia de Precisao e Personalizada, Belo Horizonte
CIONC Centro Integrado de Oncologia de Curitiba, Curitiba
Hospital do Cancer de Londrina, Londrina
Hospital Nossa Senhora da Conceicao S A, Porto Alegre
Hospital Santa Izabel Santa Casa de Misericordia da Bahia, Salvador
Fundacao Antonio Prudente A C Camargo Cancer Center, São Paulo
INSTYTUT GENETYKI I IMMUNOLOGII GENIM Sp z o o, Lublin
Wielkopolskie Centrum Pulmonologii i Torakochirurgii im. Eugenii i Janusza Zeylandow, Poznan
Narodowy Instytut Onkologii im Marii Sklodowskiej Curie Panstwowy Instytut Badawczy, Warsaw
Seoul National University Hospital, Seoul
Severance Hospital Yonsei University Health System, Seoul
Samsung Medical Center, Seoul
Hosp. Gral. Univ. de Alicante, Alicante
Hosp Univ Vall D Hebron, Barcelona
Adana City Hospital, Adana
Dr Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara
Ankara Bilkent City Hospital, Ankara
Ankara Bilkent City Hospital, Çankaya
Imperial College London and Imperial College Healthcare NHS Trust, London
Freeman Hospital, Newcastle
Royal Marsden Hospital, Sutton
Janssen Research & Development, LLC
INDUSTRY